VIDEO: Oil Stocks: Buy Here or Stay Clear?
Barron’s writer Ben Levisohn discusses the opportunities and risks in crude’s recent slide.
Barron’s writer Ben Levisohn discusses the opportunities and risks in crude’s recent slide.
Tough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.
Recent Comments